INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cumberland Pharmaceuticals Inc. - CPIX
NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cumberland Pharmaceuticals Inc. ("Cumberland" or the "Company") (NASDAQ: CPIX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....